Effectiveness and tolerability of low dose clindamycin for treatment of prosthetic joint infections, a retrospective cohort study
Jesper Ericsson, Tove Gustafsson, Olof Sköldenberg, Magnus Hedenstierna, Agata Rysinska, Johan Ursing · 2026
Read Effectiveness and tolerability of low dose clindamycin for treatment of prosthetic joint infections, a retrospective cohort study by Jesper Ericsson, Tove Gustafsson, Olof Sköldenberg, Magnus Hedenstierna, Agata Rysinska, Johan Ursing (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13571324.txt.
Description
Joint replacement parts that get infected are hard to treat, and a 2026 study by Jesper Ericsson and co-authors reviews how one antibiotic, clindamycin, performed at low dose. The drug is a backup option when first-line drugs do not suit, but a partner drug, rifampicin, is known to lower its levels in the body.
The team looked back at patients treated at one center from 2010 to 2022, given clindamycin alone or with other antibiotics. Cure meant no return of the same germ after two years of follow-up. Just under half the group received clindamycin alone. The study weighs how well each route worked and how well patients tolerated the drug in real practice.
Catalog record
| CREATOR | Jesper Ericsson, Tove Gustafsson, Olof Sköldenberg, Magnus Hedenstierna, Agata Rysinska, Johan Ursing |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 43 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |